Lidbree (Lidocaine)

Lidocaine works by blocking voltage‑gated sodium channels on nerve cells within the uterine tissue. This inhibition prevents the generation and conduction of nerve impulses, resulting in a localized loss of sensation without affecting the patient's overall consciousness.

The specific dose of Lidbree is determined by the prescribing clinician based on the type of intrauterine procedure, patient characteristics, and clinical guidelines. Healthcare professionals calculate the appropriate volume and concentration required for each individual case.

Safety of Lidbree in pregnancy and breastfeeding has not been established. It should only be used when clearly needed and after a risk‑benefit assessment by the treating physician. Women who are pregnant or nursing should discuss potential risks with their healthcare provider.

To order Lidbree, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lidbree’s active ingredient, lidocaine, is a widely used local anesthetic with a rapid onset and moderate duration of action. Compared with other intrauterine anesthetics, lidocaine offers a well‑characterized safety profile, predictable pharmacokinetics, and extensive clinical experience, making it a common choice for uterine procedures.

Lidbree should be stored below 25 °C, protected from light and moisture, and kept in its original packaging. Avoid freezing the product. Before use, inspect the solution for any discoloration or particulate matter and follow aseptic techniques during administration.

Lidbree is administered intrauterinely by a qualified healthcare professional. The solution is injected directly into the uterine cavity using a sterile catheter or applicator, following standard procedural protocols to ensure accurate placement and optimal anesthetic effect.

Serious risks, though rare, include allergic reactions such as anaphylaxis, severe hypotension, cardiac arrhythmias, methemoglobinemia, and central nervous system toxicity leading to seizures. Immediate medical attention is required if any of these symptoms occur.

Lidbree should not be used in patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics. Caution is also advised for individuals with significant cardiac conduction disorders, severe liver disease, or those taking medications that may cause additive cardiotoxic effects.